Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mithun Ghosh

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
International Journal of Molecular Sciences|January 30, 2021
Synergism of AZD6738, an ATR Inhibitor, in Combination with Belotecan, a Camptothecin Analogue, in Chemotherapy-Resistant Ovarian CancerJin Hur, Mithun Ghosh, Tae Heon Kim, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 29, 2023
Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancerNar Bahadur Katuwal, Min Sil Kang, Mithun Ghosh, et al.
Anticancer Research|December 30, 2022
Preclinical Platform Using a Triple-negative Breast Cancer Syngeneic Murine Model to Evaluate Immune Checkpoint InhibitorsNar Bahadur Katuwal, Nahee Park, Kamal Pandey, et al.
British Journal of Cancer|May 6, 2026
JPI-547, a novel dual inhibitor of PARP1/2 and tankyrase is more effective than first-generation PARP inhibitors in preclinical BRCA1/2-mutated cancer modelsMin Sil Kang, Nar Bahadur Katuwal, Mithun Ghosh, et al.
ACS Nano|March 12, 2026
Doping-Modulated Semiconductor-to-Metal Transformation in a Low-Band-Gap Two-Dimensional MaterialQi Zhang, Yaroslav Zhumagulov, Mithun Ghosh, et al.
Anticancer Research|May 27, 2025
Intratumoral Injection of Allogeneic NK Cell With Chemotherapy in a Triple-negative Breast Cancer Preclinical ModelSa Deok Hong, Min Sil Kang, Nar Bahadur Katuwal, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
International Journal of Molecular Sciences|January 30, 2021
Synergism of AZD6738, an ATR Inhibitor, in Combination with Belotecan, a Camptothecin Analogue, in Chemotherapy-Resistant Ovarian CancerJin Hur, Mithun Ghosh, Tae Heon Kim, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 29, 2023
Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancerNar Bahadur Katuwal, Min Sil Kang, Mithun Ghosh, et al.
Anticancer Research|December 30, 2022
Preclinical Platform Using a Triple-negative Breast Cancer Syngeneic Murine Model to Evaluate Immune Checkpoint InhibitorsNar Bahadur Katuwal, Nahee Park, Kamal Pandey, et al.
British Journal of Cancer|May 6, 2026
JPI-547, a novel dual inhibitor of PARP1/2 and tankyrase is more effective than first-generation PARP inhibitors in preclinical BRCA1/2-mutated cancer modelsMin Sil Kang, Nar Bahadur Katuwal, Mithun Ghosh, et al.
ACS Nano|March 12, 2026
Doping-Modulated Semiconductor-to-Metal Transformation in a Low-Band-Gap Two-Dimensional MaterialQi Zhang, Yaroslav Zhumagulov, Mithun Ghosh, et al.
Anticancer Research|May 27, 2025
Intratumoral Injection of Allogeneic NK Cell With Chemotherapy in a Triple-negative Breast Cancer Preclinical ModelSa Deok Hong, Min Sil Kang, Nar Bahadur Katuwal, et al.
Pageof 2